Work

Tenofovir alafenamide: safer, but questions remain

Year: 2016

Type: article

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(16)00039-4

Authors: Mark A Boyd, David A Cooper

Institutions: UNSW Sydney, Kirby Institute

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2300372856

FWCI: 0.308

Cites: 8

Cited by: 2

Related to: 10